Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Nav

General Info

Geography

High-income North America

Time period covered

01/2007 - 12/2010

Data type

Scientific literature

Keywords

Blood pressure

Citation

Authors

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA, ALTITUDE Investigators

Journal

N Engl J Med

Volume

367

Issue

Pages

2204-13

Publication year

2012

Suggested citation

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA, ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012; 367(23): 2204-13.

DOI

10.1056/NEJMoa1208799

PMID

23121378

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Nav